Skip to main content
  • The Lancet Retracts Negative Study of Hydroxychloroquine in COVID-19 Treatment

    Three authors of a paper recently published in The Lancet announced on Thursday that they have retracted their study, which found that there was no benefit regarding in-hospital outcomes for COVID-19 patients who were treated with chloroquine or hydroxychloroquine, either alone or with a macrolide.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details